This study is not yet accepting patients

Wearable Activity Tracking to Curb Hospitalizations

a study on Hematopoietic Neoplasm Solid Neoplasm Lymphatic System Neoplasm Neoplasms Hematologic Neoplasms

Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at San Francisco, California
Dates
study started
completion around
Principal Investigator
by Julian Hong, MD, MS
Headshot of Julian Hong
Julian Hong

Description

Summary

This study is being done to collect patient generated health data to predict the risk of patients needing emergency department visits or hospitalization before, during. and after receiving radiation therapy.

Official Title

Wearable Activity Tracking to Curb Hospitalizations (WATCH)

Details

PRIMARY OBJECTIVE:

  1. Validate a previously developed step-count model for predicting all-cause acute care (pooled across all devices).

OUTLINE: This is an observational study. Participants are assigned to 1 of 2 groups.

GROUP I: Participants receive Fitbit device and undergo non-interventional, standard of care, radiation therapy.

GROUP II: Participants receive Fitbit device and utilize their own personal Apple HealthKit-based device and and undergo non-interventional, standard of care, radiation therapy.

Keywords

Hematopoietic Neoplasm, Malignant Solid Neoplasm, Lymphatic System Neoplasm, Activity tracking, Hospitalization prevention, Artificial Intelligence (AI) modelling, Neoplasms, Hematologic Neoplasms, Fitbit, Apple HealthKit-based devices

Eligibility

You can join if…

Open to people ages 18 years and up

  • Age >= 18.
  • Eastern Cooperative Oncology Group (ECOG) performance status =< 2.
  • Able to understand study procedures and to comply with them for the entire length of the study.
  • Ability of individual or legal guardian/representative to understand a written informed consent document, and the willingness to sign it.
  • Diagnosis of invasive malignancy.
  • Able to ambulate independently (without the assistance of a cane or walker).
  • Planned treatment with fractionated external beam radiotherapy over at least 5 days (no fractional requirement).
  • Not a previous participant on this protocol for subsequent courses.

You CAN'T join if...

  • Participants bound to a wheelchair.
  • Participants unable to ambulate independently (needing assistance of cane or walker).

Location

  • UCSF
    San Francisco California 94143 United States

Lead Scientist at UCSF

  • Julian Hong, MD, MS
    Dr. Hong is Associate Professor and Medical Director of Radiation Oncology Informatics in the Department of Radiation Oncology, Division of Clinical Informatics and Digital Transformation (DoC-IT), and Bakar Computational Health Sciences Institute at the University of California, San Francisco, and in the UCSF-UC Berkeley Joint Program in Computational Precision Health.

Details

Status
not yet accepting patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT06587100
Study Type
Observational
Participants
Expecting 260 study participants
Last Updated